Suchergebnisse - (Person:"Liu, Geoffrey")

PubPharm (791)

81

Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer

enthalten in: JAMA otolaryngology-- head & neck surgery | 2023

von Noel, C. | Hueniken, K. | Forner, D. | +13

82

Clustering on longitudinal quality‐of‐life measurements using growth mixture models for clinical prognosis : Implementation on CCTG/ AGITG CO.20 trial

enthalten in: Cancer Medicine | 2023

von Zhang, J. | Kong, W. | Hu, P. | +10

83

A Bayesian approach for two‐stage multivariate Mendelian randomization with mixed outcomes

enthalten in: Statistics in Medicine | 2023

von Deng, Y. | Tu, D. | O'Callaghan, C. | +5

84

Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization

enthalten in: bioRxiv.org | 2023

von Gormley, M. | Dudding, T. | Kachuri, L. | +23

85

Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib : ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Ou, S. | Nishio, M. | Ahn, M. | +20

CommentIn: J Thorac Oncol. 2023 Mar;18(3):e28-e29. - PMID 36842817

86

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction

enthalten in: iScience | 2022

von Ul Haq, S. | Schmid, S. | Aparnathi, M. | +14

87

Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Mazieres, J. | Iadeluca, L. | Shaw, A. | +11

88

Lung Cancer Absolute Risk Models for Mortality in an Asian Population using the China Kadoorie Biobank

enthalten in: Journal of the National Cancer Institute | 2022

von Warkentin, M. | Tammemägi, M. | Espin-Garcia, O. | +3

89

KuLGaP: A Selective Measure for Assessing Therapy Response in Patient-Derived Xenografts

enthalten in: bioRxiv.org | 2022

von Ortmann, J. | Rampášek, L. | Tai, E. | +20

90

EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Sara Kuruvilla, M. | Liu, G. | Syed, I. | +17